Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
62.97
+0.25 (0.40%)
Sep 26, 2025, 4:00 PM EDT - Market closed
PBH Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for PBH stock ranges from a low of $93 to a high of $104. The average analyst price target of $98.5 forecasts a 56.42% increase in the stock price over the next year.
Price Target: $98.50 (+56.42%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 8, 2025.
Analyst Ratings
The average analyst rating for PBH stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 |
---|---|---|---|---|---|---|
Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 2 | 2 | 2 | 2 | 2 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $105 → $100 | Strong Buy | Maintains | $105 → $100 | +58.81% | Aug 8, 2025 |
RBC Capital | RBC Capital | Hold Maintains $96 → $97 | Hold | Maintains | $96 → $97 | +54.04% | Mar 21, 2025 |
Oppenheimer | Oppenheimer | Buy Maintains $87 → $93 | Buy | Maintains | $87 → $93 | +47.69% | Feb 13, 2025 |
DA Davidson | DA Davidson | Strong Buy Maintains $95 → $104 | Strong Buy | Maintains | $95 → $104 | +65.16% | Feb 7, 2025 |
Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $93 → $100 | Strong Buy | Maintains | $93 → $100 | +58.81% | Feb 7, 2025 |
Financial Forecast
Revenue This Year
1.12B
from 1.14B
Decreased by -1.74%
Revenue Next Year
1.14B
from 1.12B
Increased by 2.24%
EPS This Year
4.57
from 4.29
Increased by 6.57%
EPS Next Year
4.83
from 4.57
Increased by 5.60%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|
High | 1.2B | 1.2B | |||
Avg | 1.1B | 1.1B | |||
Low | 1.1B | 1.1B |
Revenue Growth
Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|
High | 2.7% | 6.8% | |||
Avg | -1.7% | 2.2% | |||
Low | -5.3% | -1.7% |
EPS Forecast
EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|
High | 4.78 | 5.09 | |||
Avg | 4.57 | 4.83 | |||
Low | 4.41 | 4.55 |
EPS Growth
EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
---|---|---|---|---|---|
High | 11.4% | 11.4% | |||
Avg | 6.6% | 5.6% | |||
Low | 2.8% | -0.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.